Results 191 to 200 of about 232,874 (323)

Pharmacokinetic Interaction Between Isavuconazole and Rifabutin in a Real‐World Setting

open access: yesMycoses, Volume 69, Issue 1, January 2026.
ABSTRACT Background Since rifabutin has less severe drug interactions, it is preferred over rifampin when administered concomitantly with azole antifungals. However, limited data exist to evaluate this interaction. Methods This was a single‐centre study of hospitalised patients who received concomitant isavuconazole and rifabutin prior to plasma ...
Sunish Shah   +6 more
wiley   +1 more source

Antifungal Activity of Antimicrobial Peptides and Proteins against Aspergillus fumigatus [PDF]

open access: gold, 2020
Eloise Ballard   +5 more
openalex   +1 more source

Ultraviolet C (UV‐C) Light Therapy for Equine Ulcerative Keratomycosis—An In Vitro Study

open access: yesVeterinary Ophthalmology, Volume 29, Issue 1, January 2026.
ABSTRACT Objectives To assess if an affordable, commercially available 275 nm ultraviolet C (UV‐C) device can inhibit fungal pathogens associated with equine keratomycosis and to establish the optimal exposure time/dose required in vitro. Methods Fungal inhibition zone surface areas of isolates from two fungal genera (Aspergillus and Fusarium spp ...
Mona Hoerdemann   +3 more
wiley   +1 more source

A post-COVID-19 Aspergillus fumigatus posterior mediastinitis: Case report [PDF]

open access: gold, 2022
Nadine El Hoyek   +5 more
openalex   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 23: Suitability of taxonomic units notified to EFSA until September 2025

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The qualified presumption of safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of relevant knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +28 more
wiley   +1 more source

Safety evaluation of the food enzyme abstract aspergillopepsin I from the non‐genetically modified Aspergillus niger strain CCTCC M 2023234

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The food enzyme aspergillopepsin I (EC 3.4.23.18) is produced with the non‐genetically modified Aspergillus niger strain CCTCC M 2023234 by Suntaq International Limited. The food enzyme was free from viable cells of the production organism. The food enzyme is intended to be used in eight food manufacturing processes.
EFSA Panel on Food Enzymes (FEZ)   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy